Matches in Nanopublications for { <http://bio2rdf.org/drugbank_resource:DB01033_DB04854> ?p ?o ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- drugbank_resource:DB01033_DB04854 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB01033_DB04854 label "DDI between Mercaptopurine and Febuxostat - Coadministration of febuxostat with xanthine oxidase substrate drugs (azathioprine, mercaptopurine or theophylline) could increase plasma concentrations of these drugs, since these drugs are metabolized by xanthine oxidase, resulting in severe toxicity; hence their concomitant use is contraindicated. Since febuxostat does not inhibit or induce cytochrome P450 enzymes it lacks significant drug interactions with other drugs metabolized of these enzymes. [drugbank_resource:DB01033_DB04854]" assertion.
- drugbank_resource:DB01033_DB04854 identifier "drugbank_resource:DB01033_DB04854" assertion.
- drugbank_resource:DB01033_DB04854 title "DDI between Mercaptopurine and Febuxostat - Coadministration of febuxostat with xanthine oxidase substrate drugs (azathioprine, mercaptopurine or theophylline) could increase plasma concentrations of these drugs, since these drugs are metabolized by xanthine oxidase, resulting in severe toxicity; hence their concomitant use is contraindicated. Since febuxostat does not inhibit or induce cytochrome P450 enzymes it lacks significant drug interactions with other drugs metabolized of these enzymes." assertion.